Cargando…
Post-Transplant Cyclophosphamide and Tacrolimus—Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors
Combined direct antineoplastic activity and the long-lasting immunological effects of allogeneic hematopoietic cell transplant (HCT) can cure many hematological malignancies, but broad adoption requires non-relapse mortality (NRM) rates and graft-versus-host disease (GVHD) control. Recently, posttra...
Autores principales: | Carnevale-Schianca, Fabrizio, Caravelli, Daniela, Gallo, Susanna, Becco, Paolo, Paruzzo, Luca, Poletto, Stefano, Polo, Alessandra, Mangioni, Monica, Salierno, Milena, Berger, Massimo, Pessolano, Rosanna, Saglio, Francesco, Gottardi, Daniela, Rota-Scalabrini, Delia, Grignani, Giovanni, Fizzotti, Marco, Ferrero, Ivana, Frascione, Pio Manlio Mirko, D’Ambrosio, Lorenzo, Gaidano, Valentina, Gammaitoni, Loretta, Sangiolo, Dario, Saglietto, Andrea, Vassallo, Elena, Cignetti, Alessandro, Aglietta, Massimo, Fagioli, Franca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998305/ https://www.ncbi.nlm.nih.gov/pubmed/33799685 http://dx.doi.org/10.3390/jcm10061173 |
Ejemplares similares
-
Melanoma Brain Metastases in the Era of Target Therapies: An Overview
por: Becco, Paolo, et al.
Publicado: (2020) -
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers
por: Circosta, Paola, et al.
Publicado: (2022) -
Activity of cytokine-induced killer cells against bone and soft tissue sarcoma
por: Sangiolo, Dario, et al.
Publicado: (2014) -
Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin’s lymphoma: a case report and review of the literature
por: Rota Scalabrini, Delia, et al.
Publicado: (2014) -
High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients
por: Berrino, E., et al.
Publicado: (2021)